Search Results - Gregory D. Cuny

Refine Results
  1. 1
    RIPK protein kinase family: Atypical lives of typical kinases

    RIPK protein kinase family: Atypical lives of typical kinases by Gregory D. Cuny, Alexei Degterev

    Published 2020
    Get full text
    Revisão
    Save to List
    Saved in:
  2. 2
    Glutamate Transporter EAAT2: A New Target For The Treatment Of Neurodegenerative Diseases

    Glutamate Transporter EAAT2: A New Target For The Treatment Of Neurodegenerative Diseases by Chien‐liang Glenn Lin, Qiongman Kong, Gregory D. Cuny, Marcie A. Glicksman

    Published 2012
    Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    Synthesis of Carbolines by Photostimulated Cyclization of Anilinohalopyridines

    Synthesis of Carbolines by Photostimulated Cyclization of Anilinohalopyridines by Joydev K. Laha, Silvia M. Barolo, Roberto A. Rossi, Gregory D. Cuny

    Published 2011
    Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    Development of improved inhibitors of wall teichoic acid biosynthesis with potent activity against Staphylococcus aureus

    Development of improved inhibitors of wall teichoic acid biosynthesis with potent activity against Staphylococcus aureus by Kyung‐Ae Lee, Jennifer Campbell, Jonathan G. Swoboda, Gregory D. Cuny, Suzanne Walker

    Published 2010
    Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    Type II Kinase Inhibitors Show an Unexpected Inhibition Mode against Parkinson’s Disease-Linked LRRK2 Mutant G2019S

    Type II Kinase Inhibitors Show an Unexpected Inhibition Mode against Parkinson’s Disease-Linked LRRK2 Mutant G2019S by Min Liu, Samantha Bender, Gregory D. Cuny, Woody Sherman, Marcie A. Glicksman, Soumya S. Ray

    Published 2013
    Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    Small-Molecule Klotho Enhancers As Novel Treatment Of Neurodegeneration

    Small-Molecule Klotho Enhancers As Novel Treatment Of Neurodegeneration by Carmela R. Abraham, Ci-Di Chen, Gregory D. Cuny, Marcie A. Glicksman, Ella Zeldich

    Published 2012
    Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    Development of an ALK2-Biased BMP Type I Receptor Kinase Inhibitor

    Development of an ALK2-Biased BMP Type I Receptor Kinase Inhibitor by Agustin H. Mohedas, Xuechao Xing, Kelli Armstrong, Alex N. Bullock, Gregory D. Cuny, Paul B. Yu

    Published 2013
    Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    Genetic ablation of purine salvage in <i>Cryptosporidium parvum</i> reveals nucleotide uptake from the host cell

    Genetic ablation of purine salvage in <i>Cryptosporidium parvum</i> reveals nucleotide uptake from the host cell by Mattie C. Pawlowic, Mastanbabu Somepalli, Adam Sateriale, Gillian T. Herbert, Alexis R. Gibson, Gregory D. Cuny, Lizbeth Hedstrom, Boris Striepen

    Published 2019
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    Triazole Inhibitors of <i>Cryptosporidium parvum</i> Inosine 5′-Monophosphate Dehydrogenase

    Triazole Inhibitors of <i>Cryptosporidium parvum</i> Inosine 5′-Monophosphate Dehydrogenase by Sushil K. Maurya, Deviprasad R. Gollapalli, Shivapriya Kirubakaran, Minjia Zhang, Corey R. Johnson, Nicole Benjamin, Lizbeth Hedstrom, Gregory D. Cuny

    Published 2009
    Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    Necrostatin-1 Reduces Histopathology and Improves Functional Outcome after Controlled Cortical Impact in Mice

    Necrostatin-1 Reduces Histopathology and Improves Functional Outcome after Controlled Cortical Impact in Mice by Zerong You, Sean I. Savitz, Jinsheng Yang, Alexei Degterev, Junying Yuan, Gregory D. Cuny, Michael A. Moskowitz, Michael J. Whalen

    Published 2008
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    The Structural Basis of Cryptosporidium-Specific IMP Dehydrogenase Inhibitor Selectivity

    The Structural Basis of Cryptosporidium-Specific IMP Dehydrogenase Inhibitor Selectivity by Iain Macpherson, Sivapriya Kirubakaran, Suresh Kumar Gorla, Thomas V. Riera, J. Alejandro D’Aquino, Minjia Zhang, Gregory D. Cuny, Lizbeth Hedstrom

    Published 2010
    Get full text
    Artigo
    Save to List
    Saved in:
  12. 12
    Selective and Potent Urea Inhibitors of Cryptosporidium parvum Inosine 5′-Monophosphate Dehydrogenase

    Selective and Potent Urea Inhibitors of Cryptosporidium parvum Inosine 5′-Monophosphate Dehydrogenase by Suresh Kumar Gorla, Kavitha Mandapati, Minjia Zhang, Xiaoping Liu, Lisa Sharling, Deviprasad R. Gollapalli, Boris Striepen, Lizbeth Hedstrom, Gregory D. Cuny

    Published 2012
    Get full text
    Artigo
    Save to List
    Saved in:
  13. 13
    Structure–activity relationship study of selective benzimidazole-based inhibitors of Cryptosporidium parvum IMPDH

    Structure–activity relationship study of selective benzimidazole-based inhibitors of Cryptosporidium parvum IMPDH by Sivapriya Kirubakaran, Suresh Kumar Gorla, Lisa Sharling, Minjia Zhang, Xiaoping Liu, Soumya S. Ray, Iain Macpherson, Boris Striepen, Lizbeth Hedstrom, Gregory D. Cuny

    Published 2012
    Get full text
    Artigo
    Save to List
    Saved in:
  14. 14
    Necroptosis, a novel form of caspase‐independent cell death, contributes to neuronal damage in a retinal ischemia‐reperfusion injury model

    Necroptosis, a novel form of caspase‐independent cell death, contributes to neuronal damage in a retinal ischemia‐reperfusion injury model by Daniel M. Rosenbaum, Alexei Degterev, Joel David, Pearl S. Rosenbaum, Steven Roth, James C. Grotta, Gregory D. Cuny, Junying Yuan, Sean I. Savitz

    Published 2009
    Get full text
    Artigo
    Save to List
    Saved in:
  15. 15
    In Vivo and In Vitro Pharmacological Studies of Methoxycarbonyl-Carboetomidate

    In Vivo and In Vitro Pharmacological Studies of Methoxycarbonyl-Carboetomidate by Ervin Pejo, Joseph F. Cotten, Elizabeth Kelly, Ri Le Ge, Gregory D. Cuny, Joydev K. Laha, Jifeng Liu, Xiang Lin, Douglas E. Raines

    Published 2011
    Get full text
    Artigo
    Save to List
    Saved in:
  16. 16
    Structure–Activity Relationship of 3,5-Diaryl-2-aminopyridine ALK2 Inhibitors Reveals Unaltered Binding Affinity for Fibrodysplasia Ossificans Progressiva Causing Mutants

    Structure–Activity Relationship of 3,5-Diaryl-2-aminopyridine ALK2 Inhibitors Reveals Unaltered Binding Affinity for Fibrodysplasia Ossificans Progressiva Causing Mutants by Agustin H. Mohedas, You Wang, C. Sanvitale, Peter Canning, Sung‐Woon Choi, Xuechao Xing, Alex N. Bullock, Gregory D. Cuny, Paul B. Yu

    Published 2014
    Get full text
    Artigo
    Save to List
    Saved in:
  17. 17
    Discovery of Inhibitors that Elucidate the Role of UCH-L1 Activity in the H1299 Lung Cancer Cell Line

    Discovery of Inhibitors that Elucidate the Role of UCH-L1 Activity in the H1299 Lung Cancer Cell Line by Yichin Liu, Hilal A. Lashuel, Sung‐Woon Choi, Xuechao Xing, April Case, Jake Ni, Li-An Yeh, Gregory D. Cuny, Ross L. Stein, Peter T. Lansbury

    Published 2003
    Get full text
    Artigo
    Save to List
    Saved in:
  18. 18
    Identification of Translational Activators of Glial Glutamate Transporter EAAT2 through Cell-Based High-Throughput Screening: An Approach to Prevent Excitotoxicity

    Identification of Translational Activators of Glial Glutamate Transporter EAAT2 through Cell-Based High-Throughput Screening: An Approach to Prevent Excitotoxicity by Craig K. Colton, Qiongman Kong, Li‐Ching Lai, Michael X. Zhu, Kathleen Seyb, Gregory D. Cuny, Jun Xian, Marcie A. Glicksman, Chien-Liang Lin

    Published 2010
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  19. 19
    Structure–activity relationship study of bone morphogenetic protein (BMP) signaling inhibitors

    Structure–activity relationship study of bone morphogenetic protein (BMP) signaling inhibitors by Gregory D. Cuny, Paul B. Yu, Joydev K. Laha, Xuechao Xing, Jifeng Liu, Carol Lai, Donna Y. Deng, Chetana Sachidanandan, Kenneth D. Bloch, Randall T. Peterson

    Published 2008
    Get full text
    Artigo
    Save to List
    Saved in:
  20. 20
    Enhancement of <scp>SMN</scp> protein levels in a mouse model of spinal muscular atrophy using novel drug‐like compounds

    Enhancement of <scp>SMN</scp> protein levels in a mouse model of spinal muscular atrophy using novel drug‐like compounds by Jonathan J. Cherry, Erkan Y. Osman, Matthew C. Evans, Sung‐Woon Choi, Xuechao Xing, Gregory D. Cuny, Marcie A. Glicksman, Christian L. Lorson, Elliot J. Androphy

    Published 2013
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: